Oncolytics Biotech Inc. - Common Shares (ONCY) analyst actions
Rating and price-target actions on ONCY in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ONCY overview →
1 measured ONCY analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Oncolytics Biotech® Initiates Enrollment Expansion of GOBLET Anal Cancer Cohort | Press release | +0.48% | +9.52% |
Keep exploring
More ONCY: earnings → · SEC filings → · ONCY overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| BIOSTAGE INC NEW (BSTG) | 532 | 0.00% | 22% |
| OBALON THERAPEUTICS (OBLN) | 532 | -0.09% | 42% |
| Dr. Reddy's Laboratories Ltd (RDY) | 528 | 0.00% | 47% |
| LOXO ONCOLOGY (LOXO) | 526 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.